Skip to main content
Live · TradingView
Back to the NewsWire

Syneoshealth

Published October 15, 2026 · Updated October 16, 2026

Strengthening Clinical Rigor in Psychedelic Development: Ensuring Patient Safety ...

Read the full story at Syneoshealth

Learn how sponsors can address key challenges in psychedelic trials, from expectancy bias and functional unblinding to treatment fidelity and site.

Surfaced by this Google Alert

  • Psychedelics